Review article on COVID-19 and Guillain-Barré syndrome

The tale COVID infection pandemic or as far as we might be concerned better, COVID-19, has assaulted society on a worldwide scale. For the unenlightened, the sickness is brought about by the specific infection Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is only from time to time...

Full description

Bibliographic Details
Main Author: U. Juhi Patnaik
Format: Article
Language:English
Published: IMR Press 2021-06-01
Series:Frontiers in Bioscience-Scholar
Subjects:
Online Access:https://www.imrpress.com/journal/FBS/13/1/10.52586/S555
_version_ 1811334230154674176
author U. Juhi Patnaik
author_facet U. Juhi Patnaik
author_sort U. Juhi Patnaik
collection DOAJ
description The tale COVID infection pandemic or as far as we might be concerned better, COVID-19, has assaulted society on a worldwide scale. For the unenlightened, the sickness is brought about by the specific infection Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is only from time to time that we have a pandemic seething on that has carried with itself a particularly humongous size of harm and on each and every front of the human culture, be it clinical, practical, social or pretty much anything. Theemerging coronavirus disease 2019 (COVID-19) has neurological symptoms comparable to that of the Extreme Acute Respiratory Syndrome Coronavirus (SARS-CoV) and MERS-CoV. Medical symptoms such as pain in head, vomiting, nausea, dizziness, muscle pain, anosmia, ageusia, and disorder of consciousness are present in COVID-19 affected people. These signs confirm that the COVID-19 infection affects the nervous system. But nerve affecting manifestations of COVID-19 infection are underreported. Guillain-Barré Syndrome (GBS) is a condition that often arises in various forms. According to the evaluation case reports so far from the start of COVID-19 infection, GBS could be associated with COVID-19 infection. There was a systematic review and published cases that suggested that a broad age range with male predominance was affected. There were respiratory and/or systemic symptoms in most patients and they developed GBS manifestations after COVID-19. However, asymptomatic cases of COVID-19 have also been identified. The distribution of clinical variants and electrophysiological subtypes is close to that of classical GBS, with a higher prevalence of classical sensorimotor form and acute inflammatory demyelinating polyneuropathy. It seems like it is important to pay attention to the neurological effects of COVID-19.
first_indexed 2024-04-13T17:04:47Z
format Article
id doaj.art-0244b95b25b149c7a3a18b8996ba87b7
institution Directory Open Access Journal
issn 1945-0516
language English
last_indexed 2024-04-13T17:04:47Z
publishDate 2021-06-01
publisher IMR Press
record_format Article
series Frontiers in Bioscience-Scholar
spelling doaj.art-0244b95b25b149c7a3a18b8996ba87b72022-12-22T02:38:30ZengIMR PressFrontiers in Bioscience-Scholar1945-05162021-06-011319710410.52586/S555S1945-0516(21)00003-4Review article on COVID-19 and Guillain-Barré syndromeU. Juhi Patnaik0Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, 442001 Sawangi Meghe, WardhaThe tale COVID infection pandemic or as far as we might be concerned better, COVID-19, has assaulted society on a worldwide scale. For the unenlightened, the sickness is brought about by the specific infection Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is only from time to time that we have a pandemic seething on that has carried with itself a particularly humongous size of harm and on each and every front of the human culture, be it clinical, practical, social or pretty much anything. Theemerging coronavirus disease 2019 (COVID-19) has neurological symptoms comparable to that of the Extreme Acute Respiratory Syndrome Coronavirus (SARS-CoV) and MERS-CoV. Medical symptoms such as pain in head, vomiting, nausea, dizziness, muscle pain, anosmia, ageusia, and disorder of consciousness are present in COVID-19 affected people. These signs confirm that the COVID-19 infection affects the nervous system. But nerve affecting manifestations of COVID-19 infection are underreported. Guillain-Barré Syndrome (GBS) is a condition that often arises in various forms. According to the evaluation case reports so far from the start of COVID-19 infection, GBS could be associated with COVID-19 infection. There was a systematic review and published cases that suggested that a broad age range with male predominance was affected. There were respiratory and/or systemic symptoms in most patients and they developed GBS manifestations after COVID-19. However, asymptomatic cases of COVID-19 have also been identified. The distribution of clinical variants and electrophysiological subtypes is close to that of classical GBS, with a higher prevalence of classical sensorimotor form and acute inflammatory demyelinating polyneuropathy. It seems like it is important to pay attention to the neurological effects of COVID-19.https://www.imrpress.com/journal/FBS/13/1/10.52586/S555covid-19guillain-barré syndromeinflammatorypolyneuropathysars-covmers-cov
spellingShingle U. Juhi Patnaik
Review article on COVID-19 and Guillain-Barré syndrome
Frontiers in Bioscience-Scholar
covid-19
guillain-barré syndrome
inflammatory
polyneuropathy
sars-cov
mers-cov
title Review article on COVID-19 and Guillain-Barré syndrome
title_full Review article on COVID-19 and Guillain-Barré syndrome
title_fullStr Review article on COVID-19 and Guillain-Barré syndrome
title_full_unstemmed Review article on COVID-19 and Guillain-Barré syndrome
title_short Review article on COVID-19 and Guillain-Barré syndrome
title_sort review article on covid 19 and guillain barre syndrome
topic covid-19
guillain-barré syndrome
inflammatory
polyneuropathy
sars-cov
mers-cov
url https://www.imrpress.com/journal/FBS/13/1/10.52586/S555
work_keys_str_mv AT ujuhipatnaik reviewarticleoncovid19andguillainbarresyndrome